These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29310131)

  • 1. Opportunities and Challenges in Genomic Sequencing for Precision Cancer Care.
    Cheng ML; Solit DB
    Ann Intern Med; 2018 Feb; 168(3):221-222. PubMed ID: 29310131
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Pembrolizumab (Keytruda) for cancers with biomarkers.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):e8. PubMed ID: 29294466
    [No Abstract]   [Full Text] [Related]  

  • 3. When biomarkers define a drug indication.
    Jørgensen JT
    Expert Rev Mol Diagn; 2018 Apr; 18(4):315-317. PubMed ID: 29333885
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized cancer genomics: the road map to clinical implementation.
    Yousef GM
    Clin Chem; 2012 Apr; 58(4):661-3. PubMed ID: 22322979
    [No Abstract]   [Full Text] [Related]  

  • 5. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
    Tsimberidou AM
    Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI-MATCH trial and precision medicine in gynecologic cancers.
    Barroilhet L; Matulonis U
    Gynecol Oncol; 2018 Mar; 148(3):585-590. PubMed ID: 29366510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making precision oncology the standard of care.
    The Lancet Oncology
    Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559
    [No Abstract]   [Full Text] [Related]  

  • 13. New Indication for Cancer Drug Based on Biomarkers.
    Aschenbrenner DS
    Am J Nurs; 2017 Sep; 117(9):22. PubMed ID: 28837483
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.
    Schachtschneider KM; Gaba RC
    J Vasc Interv Radiol; 2018 Aug; 29(8):1117-1121. PubMed ID: 30055782
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.
    Rodon J; Soria JC; Berger R; Miller WH; Rubin E; Kugel A; Tsimberidou A; Saintigny P; Ackerstein A; Braña I; Loriot Y; Afshar M; Miller V; Wunder F; Bresson C; Martini JF; Raynaud J; Mendelsohn J; Batist G; Onn A; Tabernero J; Schilsky RL; Lazar V; Lee JJ; Kurzrock R
    Nat Med; 2019 May; 25(5):751-758. PubMed ID: 31011205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
    Tsongalis GJ; Coleman WB
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.